Against this backdrop, this study focused on serum heparin-binding protein (HBP) and interleukin-6 (IL-6), and systematically explored their value in prognostic assessment of patients with severe pneumonia complicated with sepsis by comparing them with traditional indicators, aiming to provide a more efficient biomarker option for clinical practice. Here, AZU1 is linked to pneumonia.